[#item_full_content] Avicanna Inc (TSX: AVCN) (OTCQB: AVCNF) reported positive adjusted EBITDA for the first time during the third quarter of 2026, marking an operational milestone for the Toronto-based biopharmaceutical company.
Read More
[#item_full_content] Avicanna Inc (TSX: AVCN) (OTCQB: AVCNF) reported positive adjusted EBITDA for the first time during the third quarter of 2026, marking an operational milestone for the Toronto-based biopharmaceutical company.
Read More